Population Pharmacokinetics of Pomalidomide

A population pharmacokinetic (PPK) model of pomalidomide was developed and the influence of demographic and disease-related covariates on PPK parameters was assessed based on data from 6 clinical trials of pomalidomide (dose range, 0.5–10 mg) in healthy participants (n = 96) and patients with multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Xu, Yejun, Liu, Liangang, Wang, Xiaomin, Palmisano, Maria, Zhou, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Pharmacometrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418344/
https://www.ncbi.nlm.nih.gov/pubmed/25556560
http://dx.doi.org/10.1002/jcph.455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418344/
https://www.ncbi.nlm.nih.gov/pubmed/25556560
http://dx.doi.org/10.1002/jcph.455

Ejemplares similares